PABAL

Brand name authorized in: Austria Finland France Ireland Lithuania Netherlands Poland United Kingdom

Active ingredients

The drug PABAL contains one active pharmaceutical ingredient (API):

1 Carbetocin
UNII 88TWF8015Y - CARBETOCIN

Carbetocin selectively binds to oxytocin receptors in the smooth muscle of the uterus, stimulates rhythmic contractions of the uterus, increases the frequency of existing contractions, and raises the tone of the uterus musculature.

Read about Carbetocin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Carbetocin
H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01B Posterior pituitary lobe hormones → H01BB Oxytocin and analogues
Discover more medicines within H01BB03

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
Summary of Product Characteristics (SPC)
UK

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s): 129873
FR
Base de données publique des médicaments
Identifier(s): 62023123
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 355558
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1076900
NL
Z-Index G-Standaard, PRK
Identifier(s): 128058
PL
Rejestru Produktów Leczniczych
Identifier(s): 100162320